Background: Solid pseudopapillary pancreatic neoplasia is usually a large well-circumscribed
pancreatic mass, with cystic and solid areas more frequently found in young women.
It is a benign pancreatic neoplasia in most cases, therefore minimally invasive
surgery could be an interesting approach. Aim: Evaluate the results of minimally invasive surgery for this neoplasia. Methods: Patients with this tumor who underwent minimally invasive pancreatectomies
between 2009 and 2015 in a single institution, were analyzed regarding
demographic, clinical-pathological futures, post-operative morbidity and
disease-free survival. Results: All were women, and their median age was 39 (18-54) years. Two patients with
tumor in the head of the pancreas underwent laparoscopic pancreaticoduodenectomy,
and another one underwent laparoscopic enucleation. Two patients with tumor in the
neck underwent central pancreatectomy. Distal pancreatectomies were performed in
the other five, one with splenic preservation. None required blood transfusion or
conversion to open surgery. Two (20%) developed clinical relevant pancreatic
fistulas, requiring readmission. Median length of postoperative hospital stay was
five days (2-8). All resection margins were negative. Patients were followed for a
median of 38 months (14-71), and there was no recurrence. Conclusions: Minimally invasive surgery for solid pseudopapillary pancreatic neoplasia is
feasible for tumors in different locations in the pancreas. It was associated with
acceptable morbidity and respected the oncologic principles for treatment.
Intraperitoneal application of local anesthetics and trocar wound infiltration did not lower the pain scores in comparison with trocar wound infiltration in our study.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.